SYNERGY SCIENTECH CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.7 TWD | -1.25% |
|
-0.63% | -12.38% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,458 | 6,309 | 4,448 | 3,101 | 2,048 | 2,536 |
| Enterprise Value (EV) 1 | 2,799 | 5,902 | 4,310 | 2,863 | 1,845 | 2,155 |
| P/E ratio | 21.2 x | 39.4 x | 71.1 x | 880 x | -33.6 x | -56.4 x |
| Yield | 2.65% | 1.37% | 0.59% | - | - | - |
| Capitalization / Revenue | 1.99 x | 3.14 x | 2.48 x | 1.83 x | 1.78 x | 2.12 x |
| EV / Revenue | 1.61 x | 2.94 x | 2.4 x | 1.69 x | 1.61 x | 1.8 x |
| EV / EBITDA | 13.5 x | 24.4 x | 24.6 x | 23.7 x | -70.3 x | 50.7 x |
| EV / FCF | -28.4 x | -42.9 x | -24.2 x | -63.2 x | -40.9 x | 12.6 x |
| FCF Yield | -3.53% | -2.33% | -4.13% | -1.58% | -2.44% | 7.97% |
| Price to Book | 2.95 x | 4.52 x | 3.2 x | 1.98 x | 1.34 x | 1.73 x |
| Nbr of stocks (in thousands) | 76,344 | 86,666 | 86,881 | 93,962 | 93,750 | 93,751 |
| Reference price 2 | 45.30 | 72.80 | 51.20 | 33.00 | 21.85 | 27.05 |
| Announcement Date | 19-04-01 | 20-03-31 | 21-03-29 | 22-03-25 | 23-03-21 | 24-03-18 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,734 | 2,007 | 1,793 | 1,691 | 1,148 | 1,197 |
| EBITDA 1 | 208.1 | 242.1 | 175.4 | 120.7 | -26.26 | 42.47 |
| EBIT 1 | 182.1 | 211.6 | 103.4 | 29.09 | -122.1 | -63.64 |
| Operating Margin | 10.5% | 10.55% | 5.77% | 1.72% | -10.63% | -5.32% |
| Earnings before Tax (EBT) 1 | 221.3 | 205.4 | 78.13 | 5.745 | -86.18 | -45.48 |
| Net income 1 | 165 | 161.7 | 62.39 | 3.278 | -60.97 | -44.67 |
| Net margin | 9.51% | 8.06% | 3.48% | 0.19% | -5.31% | -3.73% |
| EPS 2 | 2.140 | 1.850 | 0.7200 | 0.0375 | -0.6509 | -0.4800 |
| Free Cash Flow 1 | -98.7 | -137.5 | -177.9 | -45.33 | -45.08 | 171.7 |
| FCF margin | -5.69% | -6.85% | -9.92% | -2.68% | -3.93% | 14.35% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 404.28% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | 1.200 | 1.000 | 0.3000 | - | - | - |
| Announcement Date | 19-04-01 | 20-03-31 | 21-03-29 | 22-03-25 | 23-03-21 | 24-03-18 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 660 | 407 | 138 | 237 | 203 | 381 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -98.7 | -138 | -178 | -45.3 | -45.1 | 172 |
| ROE (net income / shareholders' equity) | 14.1% | 11.9% | 4.47% | 0.22% | -3.94% | -2.99% |
| ROA (Net income/ Total Assets) | 7.02% | 6.13% | 2.57% | 0.68% | -3.09% | -1.83% |
| Assets 1 | 2,352 | 2,637 | 2,429 | 479.2 | 1,975 | 2,438 |
| Book Value Per Share 2 | 15.40 | 16.10 | 16.00 | 16.70 | 16.30 | 15.70 |
| Cash Flow per Share 2 | 7.620 | 10.80 | 7.830 | 11.20 | 6.720 | 8.020 |
| Capex 1 | 176 | 374 | 163 | 112 | 72.5 | 56.2 |
| Capex / Sales | 10.18% | 18.63% | 9.07% | 6.62% | 6.31% | 4.7% |
| Announcement Date | 19-04-01 | 20-03-31 | 21-03-29 | 22-03-25 | 23-03-21 | 24-03-18 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -12.38% | 69M | |
| +24.34% | 123B | |
| -11.93% | 65.11B | |
| -8.69% | 21.1B | |
| +8.11% | 17.72B | |
| -26.22% | 15.34B | |
| -9.79% | 10.76B | |
| -5.02% | 5.04B | |
| -6.14% | 4.37B | |
| +3.62% | 3.89B |
- Stock Market
- Equities
- 6558 Stock
- Financials SYNergy ScienTech Corp.
